Interestingly, analysis of signaling pathways revealed that despite inter-patient heterogeneity, some differentially expressed pathways, such as MYC signaling, initiated early at premalignant stages, while others, such as oxidative phosphorylation, were observed only in MM. Here, MYC is linked to Miyoshi myopathy.